Tsunekazu Mizushima1,2, Tadafumi Fukata3, Hiroshi Takeyama3, Hidekazu Takahashi3, Naotsugu Haraguchi3, Junichi Nishimura3, Taishi Hata3, Chu Matsuda3, Hirofumi Yamamoto3, Yuichiro Doki3, Masaki Mori3. 1. Department of Therapeutics for Inflammatory Bowel Diseases, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. tmizushima@gesurg.med.osaka-u.ac.jp. 2. Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan. tmizushima@gesurg.med.osaka-u.ac.jp. 3. Department of Surgery, Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Abstract
PURPOSE: The treatment outcomes for inflammatory bowel disease (IBD) have been improving, but the development of better therapies is needed. Stem cell therapy is promising, but little is known about the differences in adipose-derived stem cells (ADSCs) between IBD patients and healthy individuals. METHODS: ADSCs were isolated from subcutaneous adipose tissue (SAT) in IBD (Crohn's disease, 3; ulcerative colitis, 2) and non-IBD (colorectal cancer, 5; breast cancer, 1) patients. We also analyzed the effects of tumor necrosis factor (TNF)-α on murine ADSCs. RESULTS: The numbers of stromal vascular fraction (SVF) cells per gram of SAT were 7.72 ± 3.03 × 105 in IBD and 8.51 ± 8.80 × 105 in non-IBD patients (p > 0.05). The proportions of ADSCs in SVF cells were 4.98 ± 2.61% in IBD and 1.02 ± 0.67% in non-IBD patients. The numbers of ADSCs per gram of SAT were 4.16 ± 2.96 × 104 in IBD and 0.88 ± 1.04 × 104 in non-IBD patients. The proportions and numbers of ADSCs were significantly higher in IBD patients than in non-IBD patients. TNF-α significantly facilitated the proliferation and motility of murine ADSCs. CONCLUSION: These results showed the potential advantage of freshly isolated autologous ADSCs in IBD patients.
PURPOSE: The treatment outcomes for inflammatory bowel disease (IBD) have been improving, but the development of better therapies is needed. Stem cell therapy is promising, but little is known about the differences in adipose-derived stem cells (ADSCs) between IBD patients and healthy individuals. METHODS: ADSCs were isolated from subcutaneous adipose tissue (SAT) in IBD (Crohn's disease, 3; ulcerative colitis, 2) and non-IBD (colorectal cancer, 5; breast cancer, 1) patients. We also analyzed the effects of tumor necrosis factor (TNF)-α on murine ADSCs. RESULTS: The numbers of stromal vascular fraction (SVF) cells per gram of SAT were 7.72 ± 3.03 × 105 in IBD and 8.51 ± 8.80 × 105 in non-IBD patients (p > 0.05). The proportions of ADSCs in SVF cells were 4.98 ± 2.61% in IBD and 1.02 ± 0.67% in non-IBD patients. The numbers of ADSCs per gram of SAT were 4.16 ± 2.96 × 104 in IBD and 0.88 ± 1.04 × 104 in non-IBD patients. The proportions and numbers of ADSCs were significantly higher in IBD patients than in non-IBD patients. TNF-α significantly facilitated the proliferation and motility of murine ADSCs. CONCLUSION: These results showed the potential advantage of freshly isolated autologous ADSCs in IBD patients.
Authors: Marjolijn Duijvestein; Anne Christine W Vos; Helene Roelofs; Manon E Wildenberg; Barbara B Wendrich; Henricus W Verspaget; Engelina M C Kooy-Winkelaar; Frits Koning; Jaap Jan Zwaginga; Herma H Fidder; Auke P Verhaar; Willem E Fibbe; Gijs R van den Brink; Daniel W Hommes Journal: Gut Date: 2010-10-04 Impact factor: 23.059
Authors: Per Anderson; Luciana Souza-Moreira; Maria Morell; Marta Caro; Francisco O'Valle; Elena Gonzalez-Rey; Mario Delgado Journal: Gut Date: 2012-05-25 Impact factor: 23.059
Authors: Geoffrey M Forbes; Marian J Sturm; Rupert W Leong; Miles P Sparrow; Dev Segarajasingam; Adrian G Cummins; Michael Phillips; Richard P Herrmann Journal: Clin Gastroenterol Hepatol Date: 2013-07-19 Impact factor: 11.382
Authors: Shahla Hamza Al-Saqi; Mohammed Saliem; Suvi Asikainen; Hernan Concha Quezada; Asa Ekblad; Outi Hovatta; Katarina Le Blanc; Aino Fianu Jonasson; Cecilia Götherström Journal: Cytotherapy Date: 2014-04-13 Impact factor: 5.414